Literature DB >> 16113477

Pathogenesis of respiratory syncytial virus infection in the murine model.

R Stokes Peebles1, Barney S Graham.   

Abstract

There is a wide spectrum of illness caused by respiratory syncytial virus (RSV) infection that is caused in large part by host-related factors, such as age of the patient and degree of host immunocompetency. Although the vast majority of persons infected with RSV experience symptoms of mild upper respiratory tract infection, in some people these infections cause significant morbidity and are sometimes fatal. Although a great deal of investigation in both humans and animals has explained the timing and tropism of RSV infection and the general principles by which the immune system responds to this infection, at present we only partially understand the disparity in illness severity that can occur. This article briefly reviews the clinical sequelae of RSV infection and then focuses on the mechanisms of viral pathogenesis.

Entities:  

Mesh:

Year:  2005        PMID: 16113477      PMCID: PMC2713314          DOI: 10.1513/pats.200501-002AW

Source DB:  PubMed          Journal:  Proc Am Thorac Soc        ISSN: 1546-3222


  47 in total

1.  Prior airway exposure to allergen increases virus-induced airway hyperresponsiveness.

Authors:  Mika J Mäkelä; Ralph Tripp; Azzeddine Dakhama; Jun-Won Park; Toshihide Ikemura; Anthony Joetham; Matti Waris; Larry J Anderson; Erwin W Gelfand
Journal:  J Allergy Clin Immunol       Date:  2003-11       Impact factor: 10.793

2.  An outbreak of respiratory syncytial virus infection in a bone marrow transplant unit: effect on engraftment and outcome of pneumonia without specific antiviral treatment.

Authors:  A Abdallah; K E Rowland; S K Schepetiuk; L B To; P Bardy
Journal:  Bone Marrow Transplant       Date:  2003-07       Impact factor: 5.483

3.  A multicenter, randomized, double-blind, controlled trial of nebulized epinephrine in infants with acute bronchiolitis.

Authors:  Claire Wainwright; Luis Altamirano; Marise Cheney; Joyce Cheney; Scott Barber; Darrell Price; Sue Moloney; Ann Kimberley; Nick Woolfield; Susan Cadzow; Frank Fiumara; Peter Wilson; Steve Mego; Dianne VandeVelde; Sharon Sanders; Peter O'Rourke; Paul Francis
Journal:  N Engl J Med       Date:  2003-07-03       Impact factor: 91.245

4.  IL-13 is sufficient for respiratory syncytial virus G glycoprotein-induced eosinophilia after respiratory syncytial virus challenge.

Authors:  Teresa R Johnson; Robert A Parker; Joyce E Johnson; Barney S Graham
Journal:  J Immunol       Date:  2003-02-15       Impact factor: 5.422

5.  Respiratory syncytial virus up-regulates TLR4 and sensitizes airway epithelial cells to endotoxin.

Authors:  Martha M Monick; Timur O Yarovinsky; Linda S Powers; Noah S Butler; A Brent Carter; Gunnar Gudmundsson; Gary W Hunninghake
Journal:  J Biol Chem       Date:  2003-10-17       Impact factor: 5.157

6.  Respiratory syncytial virus-induced CCL5/RANTES contributes to exacerbation of allergic airway inflammation.

Authors:  Alison E John; Aaron A Berlin; Nicholas W Lukacs
Journal:  Eur J Immunol       Date:  2003-06       Impact factor: 5.532

7.  Nucleotide-mediated inhibition of alveolar fluid clearance in BALB/c mice after respiratory syncytial virus infection.

Authors:  Ian C Davis; Wayne M Sullender; Judy M Hickman-Davis; J Russell Lindsey; Sadis Matalon
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2003-08-29       Impact factor: 5.464

8.  RANTES (CCL5) production during primary respiratory syncytial virus infection exacerbates airway disease.

Authors:  Kim K Tekkanat; Hussein Maassab; Allison Miller; Aaron A Berlin; Steven L Kunkel; Nicholas W Lukacs
Journal:  Eur J Immunol       Date:  2002-11       Impact factor: 5.532

9.  Respiratory syncytial virus infection--risk factors for hospital admission: a case-control study.

Authors:  H E Nielsen; V Siersma; S Andersen; B Gahrn-Hansen; C H Mordhorst; B Nørgaard-Pedersen; B Røder; T L Sørensen; R Temme; B F Vestergaard
Journal:  Acta Paediatr       Date:  2003-11       Impact factor: 2.299

10.  Influenza- and respiratory syncytial virus-associated morbidity and mortality in the nursing home population.

Authors:  Shelley E Ellis; Christopher S Coffey; Edward F Mitchel; Robert S Dittus; Marie R Griffin
Journal:  J Am Geriatr Soc       Date:  2003-06       Impact factor: 5.562

View more
  50 in total

1.  Lambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections.

Authors:  Markus Mordstein; Eva Neugebauer; Vanessa Ditt; Birthe Jessen; Toni Rieger; Valeria Falcone; Frederic Sorgeloos; Stephan Ehl; Daniel Mayer; Georg Kochs; Martin Schwemmle; Stephan Günther; Christian Drosten; Thomas Michiels; Peter Staeheli
Journal:  J Virol       Date:  2010-03-24       Impact factor: 5.103

2.  The fusion protein of respiratory syncytial virus triggers p53-dependent apoptosis.

Authors:  Julia Eckardt-Michel; Markus Lorek; Diane Baxmann; Thomas Grunwald; Günther M Keil; Gert Zimmer
Journal:  J Virol       Date:  2008-01-23       Impact factor: 5.103

3.  BRD4 Couples NF-κB/RelA with Airway Inflammation and the IRF-RIG-I Amplification Loop in Respiratory Syncytial Virus Infection.

Authors:  Bing Tian; Jun Yang; Yingxin Zhao; Teodora Ivanciuc; Hong Sun; Roberto P Garofalo; Allan R Brasier
Journal:  J Virol       Date:  2017-02-28       Impact factor: 5.103

4.  Altered Treg and cytokine responses in RSV-infected infants.

Authors:  Allison F Christiaansen; Muhammad A Syed; Patrick P Ten Eyck; Stacey M Hartwig; Lakshmi Durairaj; Sameer S Kamath; Steven M Varga
Journal:  Pediatr Res       Date:  2016-06-21       Impact factor: 3.756

5.  Central Role of the NF-κB Pathway in the Scgb1a1-Expressing Epithelium in Mediating Respiratory Syncytial Virus-Induced Airway Inflammation.

Authors:  Bing Tian; Jun Yang; Yingxin Zhao; Teodora Ivanciuc; Hong Sun; Maki Wakamiya; Roberto P Garofalo; Allan R Brasier
Journal:  J Virol       Date:  2018-05-14       Impact factor: 5.103

6.  Plasticity and virus specificity of the airway epithelial cell immune response during respiratory virus infection.

Authors:  Ioannis Ioannidis; Beth McNally; Meredith Willette; Mark E Peeples; Damien Chaussabel; Joan E Durbin; Octavio Ramilo; Asuncion Mejias; Emilio Flaño
Journal:  J Virol       Date:  2012-03-07       Impact factor: 5.103

7.  Gene expression of nucleic acid-sensing pattern recognition receptors in children hospitalized for respiratory syncytial virus-associated acute bronchiolitis.

Authors:  Carolina Scagnolari; Fabio Midulla; Alessandra Pierangeli; Corrado Moretti; Enea Bonci; Rosaria Berardi; Daniela De Angelis; Carla Selvaggi; Paola Di Marco; Enrico Girardi; Guido Antonelli
Journal:  Clin Vaccine Immunol       Date:  2009-04-22

Review 8.  Epidemiologic, experimental, and clinical links between respiratory syncytial virus infection and asthma.

Authors:  Shyam S Mohapatra; Sandhya Boyapalle
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

9.  Identification of gene biomarkers for respiratory syncytial virus infection in a bronchial epithelial cell line.

Authors:  Yuh-Chin T Huang; Zhuowei Li; Xhevahire Hyseni; Michael Schmitt; Robert B Devlin; Edward D Karoly; Joleen M Soukup
Journal:  Genomic Med       Date:  2009-05-15

Review 10.  The infectious march: the complex interaction between microbes and the immune system in asthma.

Authors:  Terianne Wong; Gary Hellermann; Shyam Mohapatra
Journal:  Immunol Allergy Clin North Am       Date:  2010-11       Impact factor: 3.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.